Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Return on Sales [ROS] (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Return on Sales [ROS] of 11.06% for Q3 2026, up 2.09 percentage points from 8.97% a year earlier but down 5.24 percentage points from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Return on Sales [ROS] (2017 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at Amneal Pharmaceuticals was 14.99%, up 2.80 percentage points year-over-year; for FY2025, it came in at 13.05%, up 4.13 percentage points from FY2024.

  • Annual Return on Sales [ROS] has increased for three consecutive years, with a five-year change of +8.48 percentage points (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Return on Sales [ROS] was 8.92% in FY2024 (+0.39 pp), 8.54% in FY2023 (+12.83 pp), -4.29% in FY2022 (-11.59 pp) and 7.29% in FY2021 (+2.72 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -35.51% in Q2 2022 to a high of 19.62% in Q1 2026 over five years.
  • On a year-over-year basis, Return on Sales [ROS] has increased in each of the last four quarters, with an average year-over-year change of +4.23 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2023, with a gain of 48.88 percentage points; the weakest was Q2 2022, with a drop of 48.05 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 16.30% (Q2 2026), 19.62% (Q1 2026) and 13.76% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 24.35%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 36.01%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 30.74%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 29.12%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 41.71%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 32.98%
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 11.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.06%
Jun 30, 2026 16.30%
Mar 31, 2026 19.62%
Dec 31, 2025 13.76%
Sep 30, 2025 8.97%
Jun 30, 2025 15.37%
Mar 31, 2025 14.43%
Dec 31, 2024 10.38%
Sep 30, 2024 12.64%
Jun 30, 2024 13.60%
Mar 31, 2024 -1.63%
Dec 31, 2023 2.30%
Sep 30, 2023 12.20%
Jun 30, 2023 13.37%
Mar 31, 2023 6.18%
Dec 31, 2022 5.91%
Sep 30, 2022 8.13%
Jun 30, 2022 -35.51%
Mar 31, 2022 4.68%
Dec 31, 2021 2.08%
API Access

Amneal Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AMRX&period=max&api_key=YOUR_API_KEY